0001666071-24-000017.txt : 20240103 0001666071-24-000017.hdr.sgml : 20240103 20240103195950 ACCESSION NUMBER: 0001666071-24-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynton Nicholas Hollmeyer CENTRAL INDEX KEY: 0001941467 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 24509311 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] ORGANIZATION NAME: 06 Technology IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 4100 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 4100 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wk-form4_1704329973.xml FORM 4 X0508 4 2024-01-01 0 0001666071 Cardlytics, Inc. CDLX 0001941467 Lynton Nicholas Hollmeyer 675 PONCE DE LEON AVENUE NE SUITE 4100 ATLANTA GA 30308 0 1 0 0 Chief Legal & Privacy Officer 0 Common Stock 2024-01-01 4 M 0 25000 A 69310 D Common Stock 2024-01-01 4 M 0 1578 A 70888 D Common Stock 2024-01-01 4 M 0 581 A 71469 D Common Stock 2024-01-03 4 S 0 15620 7.77 D 55849 D Restricted Stock Unit 2024-01-01 4 M 0 25000 0 D Common Stock 25000 25000 D Restricted Stock Unit 2024-01-01 4 M 0 1578 0 D Common Stock 1578 15780 D Restricted Stock Unit 2024-01-01 4 M 0 581 0 D Common Stock 581 5231 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on January 1, 2024. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.50 to $8.3825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023, October 1, 2023 and January 1, 2024. An additional 25% of the RSU award shall vest on April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through the vesting date. This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. /s/ Nick Lynton, Attorney-in-Fact 2024-01-03